研究与报告
2026年9月22日•1 分钟阅读
Ewha Womans University Medical Center Partners with German University for Gender Medicine Research
Ewha Womans University Medical Center and Germany's Jena University School of Medicine signed an MOU to launch joint research and education in gender medicine and gender innovation.
研究与报告
2026年9月20日•1 分钟阅读
Liver Cancer Treatment Must Balance Tumor Removal and Liver Function
Effective liver cancer therapy requires assessing both tumor size and remaining liver function to avoid severe hepatic deterioration.
研究与报告
2026年9月13日•1 分钟阅读
ArcGen Bio selected as lead institute for govt pharma‑bio venture collaboration project
ArcGen Bio has been chosen as the lead research institute for the Ministry of SMEs and Startups' pharma‑bio venture collaboration project, receiving 30 billion KRW over three years, with LG Chem joining as a co‑research partner on a multi‑specific T‑cell engager immuno‑oncology drug.
研究与报告
2026年9月2日•1 分钟阅读
Eli Lilly and Novo Nordisk Lead AI Platform Citations Among Pharma Companies
Eli Lilly and Novo Nordisk top AI platform citations, surpassing Merck, AbbVie, J&J and Pfizer, driven by GLP‑1 therapy interest.
研究与报告
2026年9月1日•1 分钟阅读
AI Chatbots Mirror Social Bias Toward Mental Illness and HIV Patients, Study Finds
A study by Beijing University researchers published in Nature Health shows AI chatbots like ChatGPT, Claude, and DeepSeek reflect societal prejudice against people with mental disorders and HIV.
研究与报告
2026年8月31日•1 分钟阅读
Keenova Therapeutics' Xiaflex Meets Primary Endpoint in Phase 3 Plantar Fibromatosis Trial
Xiaflex, the injectable enzyme already approved for Dupuytren's contracture and Peyronie's disease, achieved the primary endpoint in a phase 3 study of 436 plantar fibromatosis patients, opening a potential third indication.
研究与报告
2026年8月30日•1 分钟阅读
AI in Pharma Faces Data‑Gathering Delays, Not Scientific Limits
A recent note says most of the two‑week deviation investigation time is spent on data collection, not science, highlighting a bottleneck for AI tools in pharma.
研究与报告
2026年8月24日•1 分钟阅读
Novo targeted by hacking groups in multi‑million ransomware attempt
Two separate hacking rings accessed confidential Novo data and allegedly tried to extort the company for multi‑million‑dollar ransom payments.
研究与报告
2026年8月23日•1 分钟阅读
PMDA Updates One-Stop Service Platform by ENSEMBLExJ
The Pharmaceuticals and Medical Devices Agency (PMDA) has refreshed the One-Stop Service Platform page for ENSEMBLExJ, providing updated information for stakeholders.